3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Eating
5
Standard of Care
4
Radiofrequency Ablation
4
Exercise
4
Endoscopic Mucosal Resection
4
Surgical Procedures, Operative
3
Radiosurgery
3
Adrenalectomy
3
lutetium Lu 177 dotatate
2
Yoga
2
Saline Solution
2
Robotic Surgical Procedures
2
Resistance Training
2
Proton Therapy
2
Propofol
2
Palliative Care
2
Octreotide
2
Magnetic Resonance Imaging
2
Lutetium-177
2
Liquid Biopsy
2
Interviews as Topic
2
Hydrocortisone
2
Diet, Mediterranean
2
Diet
2
Desflurane
2
Data Collection
2
Conversion to Open Surgery
2
Control Groups
2
Calcium
2
3-Iodobenzylguanidine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Poly(ADP-ribose) Polymerase Inhibitors
×
Endocrine
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled